Search results

Safety Pharmacology Society Annual Meeting (SPS 2025)
www.richmondresearchinstitute.org/news/safety-pharmacology-society-annual-meeting-sps-2025

Safety Pharmacology Society Annual Meeting (SPS 2025). 13th October 2025. Richmond Pharmacology is pleased to share that we will be presenting at the. Safety Pharmacology Society Annual Meeting (SPS 2025). , taking place from. 13–15 October.…

Videos - Richmond Research Institute
www.richmondresearchinstitute.org/videos

Work with Richmond Pharmacology. Watch Video. Senior Research Physician - Consider a career in Clinical Research. Watch Video. Acute Clinical Management - Consider a career in Clinical Research. Watch Video. Health Science Apprentice Practitioner.…

Dr Ulrike Lorch - Group Scientific lead – Clinical Trial Design and Methodology
www.richmondresearchinstitute.org/scientific-team/dr-ulrike-lorch

Dr Lorch is the Director of Human Pharmacology at the Faculty of Pharmaceutical Medicine and Educational Supervisor for physicians participating in Pharmaceutical Medicine Specialty Training.…

Dr Jorg Taubel - Institute Director and Scientific Lead
www.richmondresearchinstitute.org/scientific-team/dr-jorg-taubel

Dr Jorg Taubel is an expert in clinical pharmacology with a special interest in cardiac repolarisation changes related to iatrogenic interference with glucostasis.…

First patient enrolled in telehealth study, the Pathway Study
www.richmondresearchinstitute.org/news/first-patient-enrolled-in-telehealth-study-the-pathway-study

The Pathway study is based on pioneering work during the pandemic between clinicians at Richmond Pharmacology and the National Amyloidosis Centre and aims to help patients with the complex disease ATTR amyloidosis avoid A&E and be monitored and treated remotely…

AHA Scientific Sessions 2025
www.richmondresearchinstitute.org/news/aha-scientific-sessions-2025

Richmond Pharmacology is excited to confirm our attendance at AHA Scientific Sessions 2025, hosted by the American Heart Association in New Orleans from 8–10 November. Representing Richmond at AHA 2025: Dr Jörg Täubel, Chief Executive Officer.…

Phase I study confirms cardiac safety of potential alopecia treatment
www.richmondresearchinstitute.org/news/phase-i-study-confirms-cardiac-safety-of-potential-alopecia-treatment

A total of 32 healthy men and women between 18 and 40 years of age took part in the study at our state-of-the-art clinical research facility at Richmond Pharmacology, London.…

Professor Giuseppe Rosano - Scientific Lead – Cardiac Health: Sex
www.richmondresearchinstitute.org/scientific-team/professor-giuseppe-rosano

He is Professor of Pharmacology by Italian qualification.…

Professor Kevin Moore - Scientific Lead - Hepatology
www.richmondresearchinstitute.org/scientific-team/professor-kevin-moore

He is triply accredited in hepatology, general internal medicine as well as Clinical Pharmacology and Therapeutics. He continues to work as an acute physician.…

Results of landmark gene editing study for ATTR Amyloidosis presented at the International Liver Congress 2022
www.richmondresearchinstitute.org/news/results-of-landmark-gene-editing-study-for-attr-amyloidosis-presented-at-the-international-liver-congress-2022

Richmond Pharmacology are leaders in trialling CRISPR gene editing therapies in patients for the first time and were the UK based contract research organisation to deliver the first-in-human study.…

We work with partners at the following organisations: 

richmond research institute

We have a track record in conducting clinical research.

Publications

We present our scientific findings at meetings.

Videos

Our academic research helps improve lives and strengthens scientific insights.

Research